Bio-Techne logo

Bio-TechneNASDAQ: TECH

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

09 February 1989

Next earnings report:

31 January 2025

Last dividends:

08 November 2024

Next dividends:

N/A
$11.60 B
-42%vs. 3y high
93%vs. sector
-33%vs. 3y high
88%vs. sector
-55%vs. 3y high
83%vs. sector
-51%vs. 3y high
78%vs. sector

Price

pre-market | 107 min ago
$73.00+$2.22(+3.14%)
$289.46 M$286.03 M
$289.46 M$33.60 M

Analysts recommendations

Institutional Ownership

TECH Latest News

Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket
zacks.com30 October 2024 Sentiment: POSITIVE

TECH is experiencing ongoing growth in its Diagnostics and Spatial Biology division.

Bio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares rise
reuters.com30 October 2024 Sentiment: POSITIVE

On Wednesday, Bio-Techne exceeded profit expectations for the first quarter, thanks to growth in its diagnostics and spatial biology areas. This news caused the biotech company's shares to rise by 4.59% in premarket trading.

ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics
prnewswire.com29 October 2024 Sentiment: POSITIVE

On October 29, 2024, in St. Paul, Minnesota, ScaleReady, together with Wilson Wolf Manufacturing and Bio-Techne Corporation, announced that Luminary Therapeutics has received a G-Rex® Grant worth $300,000.

LINCOLN TECH ANNOUNCES PARTNERSHIP WITH HYUNDAI MOTOR AMERICA & GENESIS MOTOR AMERICA; TRAINING OFFERED AT NO ADDITIONAL COST TO STUDENTS
globenewswire.com21 October 2024 Sentiment: POSITIVE

A new training program is being introduced to address the increasing need for Hyundai and Genesis automotive technicians across the country. This initiative aims to prepare more skilled workers for these roles. It responds to the rising demand in the automotive industry.

CYBER ENVIRO-TECH INC ANNOUNCES PARTNERSHIP WITH SOME OF ITS SHAREHOLDERS TO FOCUS ON THE LAUNDRY INDUSTRY
prnewswire.com10 October 2024 Sentiment: POSITIVE

SCOTTSDALE, Ariz., Oct. 10, 2024 /PRNewswire/ -- Cyber Enviro-Tech Inc. (CETI) (OTCQB: CETI) is excited to share that it has formed a partnership with its subsidiary, CETI Axenic (CAX), which is owned by its shareholders, to explore possibilities in the commercial laundry sector.

ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences
prnewswire.com09 October 2024 Sentiment: POSITIVE

The award will help with the clinical production of the Company's promising Neutrophil-only Leukocyte Infusion Therapy (N-LIfT) platform in St. Paul, Minnesota.

ScaleReady announces a G-Rex® Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute
prnewswire.com08 October 2024 Sentiment: POSITIVE

On October 8, 2024, in St. Paul, Minnesota, ScaleReady™ announced a partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™. They revealed that Eric Tran, Ph.D., is now an Associate Member of the Earle A.

ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff
prnewswire.com07 October 2024 Sentiment: POSITIVE

On October 7, 2024, in St. Paul, Minnesota, ScaleReady™ announced a partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™. Christopher A. was mentioned in their announcement.

ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape
prnewswire.com18 September 2024 Sentiment: POSITIVE

On September 18, 2024, in St. Paul, Minnesota, ScaleReady™ announced a partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™ to work with ImmunoScape Pte.

ODDITY TECH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ODDITY Tech Ltd. - ODD
accesswire.com12 September 2024 Sentiment: NEGATIVE

NEW ORLEANS, LA / ACCESSWIRE / September 12, 2024 / Kahn Swick & Foti, LLC ("KSF") and their partner, former Louisiana Attorney General Charles C. Foti, Jr., want to remind investors that the deadline to submit lead plaintiff applications in a securities class action lawsuit against ODDITY Tech Ltd. is September 17, 2024.

What type of business is Bio-Techne?

Bio-Techne Corporation and its subsidiaries develop, manufacture, and sell biological reagents, tools, and services for research, diagnostic, and bioprocessing markets worldwide. The company was founded in 1976. The headquarters is located in Minneapolis, Minnesota. The corporation has a deep product portfolio and expertise in applications, selling essential components for scientific research of biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology, and progression of specific diseases. Bio-Techne products help create drugs and provide tools for precise clinical tests and diagnoses.

What sector is Bio-Techne in?

Bio-Techne is in the Healthcare sector

What industry is Bio-Techne in?

Bio-Techne is in the Biotechnology industry

What country is Bio-Techne from?

Bio-Techne is headquartered in United States

When did Bio-Techne go public?

Bio-Techne initial public offering (IPO) was on 09 February 1989

What is Bio-Techne website?

https://www.bio-techne.com

Is Bio-Techne in the S&P 500?

Yes, Bio-Techne is included in the S&P 500 index

Is Bio-Techne in the NASDAQ 100?

No, Bio-Techne is not included in the NASDAQ 100 index

Is Bio-Techne in the Dow Jones?

No, Bio-Techne is not included in the Dow Jones index

When was Bio-Techne the previous earnings report?

No data

When does Bio-Techne earnings report?

The next expected earnings date for Bio-Techne is 31 January 2025